BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10789568)

  • 1. Point-of-care testing: inspection preparedness.
    Bennett J; Cervantes C; Pacheco S
    Perfusion; 2000 Mar; 15(2):137-42. PubMed ID: 10789568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point of care testing: regulation and accreditation.
    Carlson DA
    Clin Lab Sci; 1996; 9(5):298-302; quiz 303-4. PubMed ID: 10163657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory compliance for point-of-care testing: 2009 United States perspective.
    Ehrmeyer SS; Laessig RH
    Clin Lab Med; 2009 Sep; 29(3):463-78. PubMed ID: 19840680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLIA program; approval of the College of American Pathologists--HCFA. Notice.
    Fed Regist; 1995 Feb; 60(27):7774-80. PubMed ID: 10141154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Satisfying regulatory and accreditation requirements for quality control.
    Ehrmeyer SS
    Clin Lab Med; 2013 Mar; 33(1):27-40. PubMed ID: 23331727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final CLIA regulations. Clinical Laboratory Improvement Amendments.
    Health Devices; 1992 Nov; 21(11):420-5. PubMed ID: 1428896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA)--HCFA. Final rule with comment period.
    Fed Regist; 1992 Feb; 57(40):7002-186. PubMed ID: 10170937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLIA program; simplifying CLIA regulations relating to accreditation, exemption of laboratories under a state licensure program, proficiency testing, and inspection--HCFA. Correction.
    Fed Regist; 1998 Jun; 63(114):32699. PubMed ID: 10180277
    [No Abstract]   [Full Text] [Related]  

  • 9. CLIA program; simplifying CLIA regulations relating to accreditation, exemption of laboratories under a state licensure program, proficiency testing, and inspection--HCFA. Final rule.
    Fed Regist; 1998 May; 63(93):26722-38. PubMed ID: 10179342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance, an administrative means to a managerial end: Part IV.
    Clark GB
    Clin Lab Manage Rev; 1992; 6(5):426-40; discussion 441. PubMed ID: 10122817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Documentation of quality control and operator training at point-of-care testing: a College of American Pathologists Q-Probes study of 106 institutions.
    Dyhdalo KS; Howanitz PJ; Wilkinson DS; Souers RJ; Jones BA
    Arch Pathol Lab Med; 2014 Nov; 138(11):1444-8. PubMed ID: 25357106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surviving a CLIA inspection.
    Weatherhead SK
    MLO Med Lab Obs; 1996 Sep; 28(9):26, 30, 32. PubMed ID: 10160195
    [No Abstract]   [Full Text] [Related]  

  • 13. How accelerated regulation will affect point-of-care testing.
    Krienitz D; Little J
    MLO Med Lab Obs; 1991; 23(9S Spec No):47-51. PubMed ID: 10170836
    [No Abstract]   [Full Text] [Related]  

  • 14. Approval of the Commission on Office Laboratory Accreditation for Immunohematology--HCFA. Notice.
    Fed Regist; 1997 May; 62(96):27262. PubMed ID: 10167535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory requirements (CLIA '88, JCAHO, CAP) for decentralized testing.
    Ehrmeyer SS; Laessig RH
    Am J Clin Pathol; 1995 Oct; 104(4 Suppl 1):S40-9. PubMed ID: 7484948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quest for quality blood banking program in the new millennium the American way.
    Kim DU
    Int J Hematol; 2002 Aug; 76 Suppl 2():258-62. PubMed ID: 12430934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interinstitutional comparison of bedside blood glucose monitoring program characteristics, accuracy performance, and quality control documentation: a College of American Pathologists Q-Probes study of bedside blood glucose monitoring performed in 226 small hospitals.
    Novis DA; Jones BA
    Arch Pathol Lab Med; 1998 Jun; 122(6):495-502. PubMed ID: 9625416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving quality reproducible results and maintaining compliance in molecular diagnostic testing of human papillomavirus.
    Seabrook JM; Hubbard RA
    Arch Pathol Lab Med; 2003 Aug; 127(8):978-83. PubMed ID: 12873170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance, an administrative means to a managerial end: Part III.
    Clark GB
    Clin Lab Manage Rev; 1991; 5(6):463-6, 468-70, 472-5. PubMed ID: 10116379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management.
    Lewandrowski K; Gregory K; Macmillan D
    Arch Pathol Lab Med; 2011 Nov; 135(11):1405-14. PubMed ID: 22032566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.